secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001013762-25-001833
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OSR Holdings appoints Dr. Constance Höfer as Chief Scientific Officer
---------------------------------------------------------------------

- Dr. Höfer appointed CSO effective March 24, 2025; oversees scientific strategy and innovation pipeline.
- Over 20 years experience in oncology/immunology; previously led global programs at Merck Healthcare.
- Employment agreement: $300,000 base salary plus equity compensation and customary benefits.
- No family relationships with directors/officers and no reportable related-party transactions.
- Appointment aims to strengthen R&D capabilities and accelerate drug development across multiple modalities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000101376225001833/0001013762-25-001833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000101376225001833/ea0235479-8k_osrhold.htm
  HTML page:      https://secwatch.observer/filing/0001013762-25-001833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer